| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
77,921,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,773,204 |
Avg
Vol: |
2,175,956 |
| 52
Week Range: |
$81.49 - $81.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
• – – |
2008-12-15 |
4 |
D |
$75.29 |
$113,161 |
D/D |
(1,503) |
52,202 |
|
- |
|
| Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
• – – |
2008-12-15 |
4 |
D |
$75.29 |
$114,591 |
D/D |
(1,522) |
63,352 |
|
- |
|
| Buchi J Kevin |
Exec. V.P., CFO |
• – – |
2008-12-15 |
4 |
D |
$75.29 |
$121,669 |
D/D |
(1,616) |
79,351 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2008-12-15 |
4 |
D |
$75.29 |
$603,976 |
D/D |
(8,022) |
496,858 |
|
- |
|
| Baldassano Valli F. |
Exec. VP, Chief Compliance Off |
• – – |
2008-12-15 |
4 |
D |
$75.29 |
$21,608 |
D/D |
(287) |
18,463 |
|
- |
|
| Russell Lesley |
Exec. V.P., Chief Medical |
• – – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
45,301 |
|
- |
|
| Savini Carl A |
EVP, Chief Admin. Off |
• – – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
64,931 |
|
- |
|
| Savini Carl A |
EVP, Chief Admin. Off |
• – – |
2008-12-11 |
4/A |
A |
$0.00 |
$0 |
D/D |
15,000 |
58,931 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2008-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,706 |
478,105 |
|
- |
|
| Vaught Jeffry L |
Exec. V.P., Chief Scientific |
• – – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
61,878 |
|
- |
|
| Pappert Gerald J. |
Exec. V.P., General Counsel |
• – – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
| Buchi J Kevin |
Exec. V.P., CFO |
• – – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
80,967 |
|
- |
|
| Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
• – – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
53,705 |
|
- |
|
| Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
• – – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
64,874 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
503,980 |
|
- |
|
| Baldassano Valli F. |
Exec. V.P., Chief Compliance |
• – – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
18,750 |
|
- |
|
| Buchi J Kevin |
EVP & CFO |
• – – |
2008-12-03 |
4 |
S |
$74.28 |
$1,114,200 |
D/D |
(15,000) |
65,967 |
|
- |
|
| Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
• – – |
2008-12-01 |
4/A |
D |
$68.85 |
$104,790 |
D/D |
(1,522) |
49,874 |
|
- |
|
| Buchi J Kevin |
Exec. V.P., CFO |
• – – |
2008-12-01 |
4 |
D |
$68.85 |
$111,262 |
D/D |
(1,616) |
80,967 |
|
- |
|
| Vaught Jeffry L |
Exec. V.P., Chief Scientific |
• – – |
2008-12-01 |
4 |
D |
$68.85 |
$103,550 |
D/D |
(1,504) |
46,878 |
|
- |
|
| Savini Carl A |
EVP,Chief Admin. Off. |
• – – |
2008-12-01 |
4 |
D |
$68.85 |
$103,550 |
D/D |
(1,504) |
43,931 |
|
- |
|
| Russell Lesley |
Exec. V.P., Chief Medical |
• – – |
2008-12-01 |
4 |
D |
$68.85 |
$11,085 |
D/D |
(161) |
30,301 |
|
- |
|
| Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
• – – |
2008-12-01 |
4 |
D |
$68.85 |
$107,406 |
D/D |
(1,560) |
49,836 |
|
- |
|
| Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
• – – |
2008-12-01 |
4 |
D |
$68.85 |
$103,550 |
D/D |
(1,504) |
38,705 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2008-12-01 |
4 |
D |
$68.85 |
$552,315 |
D/D |
(8,022) |
423,980 |
|
- |
|
491 Records found
|
|
Page 7 of 20 |
|
|
